$INO News

Inovio Nears FDA Decision on INO-3107 as Oct. 30 PDUFA Date Looms

Inovio Pharmaceuticals, Inc. (INO) Presents at H.C. Wainwright 28th Annual Global Investment Conference Prepared Remarks Transcript

Inovio Pharmaceuticals, Inc. (INO) Presents at 12th Annual Cantor Fitzgerald Global Healthcare Conference Transcript

INOVIO to Participate in Upcoming Investor Conferences

Inovio: The Final Countdown To A Binary FDA Decision

Jefferies Upgrades Inovio Pharmaceuticals to Buy, Raises Price Target to $3

Inovio Pharmaceuticals Inc (INO) (Q2 2026) Earnings Call Highlights: INO-3107 on Track for ...

Inovio Pharmaceuticals, Inc. Q2 2026 Earnings Call Summary

Inovio Pharmaceuticals, Inc. 2026 Q2 - Results - Earnings Call Presentation

INOVIO Reports Second Quarter 2026 Financial Results and Recent Business Highlights

Inovio Pharmaceuticals, Inc. (INO) Q2 2026 Earnings Call Transcript

Inovio Pharmaceuticals Q2 EPS $(0.07) Beats $(0.22) Estimate

INOVIO to Report Second Quarter Financial Results on August 12, 2026

Piper Sandler Reiterates Overweight on Inovio Pharmaceuticals, Lowers Price Target to $4

INOVIO Announces Pricing of $20.0 Million Public Offering

INOVIO Announces Proposed Public Offering

INOVIO Pharmaceuticals Announces Proposed Public Offering Of Shares And Warrants

Inovio Pharmaceuticals May Offer Up To $300 Mln Of Securities

Inovio Pharmaceuticals, Inc. (INO) Presents at Jefferies Global Healthcare Conference 2026 Transcript

HC Wainwright & Co. Maintains Neutral on Inovio Pharmaceuticals, Lowers Price Target to $2.5